share_log

Xilio Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Takeda Pharmaceutical Company Limited(4%),Takeda Ventures, Inc(4%)

SEC announcement ·  Jul 31 07:51
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more